Clinical trial
Once-daily Highly Active Antiretroviral Treatment Regimen Administration in…
NCT00122538 · French National Agency for Research on AIDS and Viral Hepatitis, Other · Completed
Key facts
| NCT number | NCT00122538 |
|---|---|
| Title | Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME) |
| Official title | HAART Regimen Comprising 3TC + ddI + EFV in Once-daily Administration in HIV-1 Infected Children in Burkina Faso |
| Lead sponsor | French National Agency for Research on AIDS and Viral Hepatitis, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, AIDS |
| Intervention type | Drug |
| Interventions | Efavirenz (EFV), Lamivudine (3TC), Didanosine (ddI) |
| Enrollment | 52 |
| Start date | Feb 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | May 1, 2009 |
| First posted | Jul 22, 2005 |
| Last update posted | Dec 5, 2011 |
| Countries | Burkina Faso |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: